News View all news
Trump administration projects up to 240,000 coronavirus deaths in U.S., even with mitigation efforts
The Trump administration on Tuesday gave its most dire assessment to date of the coronavirus pandemic, predicting a best-case scenario of 100,000 to 240,000 fatalities in the United States. The U.S. death toll approached 4,000, with approximately 800 Americans reported dead on Tuesday alone, the highest number of daily deaths yet.
APhA coronavirus watch: DEA says schedule II prescriptions by phone are OK in emergencies
According to guidance released Monday, March 30, DEA will allow oral prescriptions of schedule II controlled substances when they are needed for the proper treatment of a patient, there are no appropriate treatment options, and when submitting an electronic or paper prescription to the pharmacy prior to dispensing the substance is not possible. Prescribers can make the determination based on whether individual patients’ circumstances meet these criteria—not all controlled II prescriptions will be prescribed by phone.
APhA and other groups respond to PCMA brief in PBM Supreme Court case
On March 25, APhA, the National Community Pharmacists Association (NCPA), and the Arkansas Pharmacists Association (APA), responded to the brief that the Pharmaceutical Care Management Association (PCMA), the association that represents PBMs, filed with the U.S. Supreme Court in the case of Rutledge v PCMA.
APhA coronavirus watch: Inappropriate prescribing poses dilemma for pharmacists
There is scant evidence that chloroquine/hydroxychloroquine, alone or in combination with azithromycin, are effective treatments for COVID-19—but in the face of uncertainty and encouragement from President Trump, many health professionals have seized on their use. As pharmacies across the country have been flooded with fill requests for the drugs, troubling pharmacists and potentially contributing to shortages, pharmacy, medical groups, and state boards have taken a stand against the phenomenon.
Restrictions are slowing coronavirus infections, new data suggest
Stay-at-home orders and other social distancing measures are contributing to rapid drops in the numbers of fevers recorded in states across the country, according to new data from the medical technology firm Kinsa Health. At least 248 million Americans in at least 29 states have been told to stay at home.
March 31, 2020
Protect yourselves and your patients from bogus COVID-19 cures,…
Here’s an understatement: Buyer beware! We’re getting reports of scams, counterfeit products, and bogus personal protection equipment (PPE) being offered online and through various channels. Some…0 comments
March 31, 2020
APhA Creates COVID-19 Training Programs and Resources for Pharmacists
Pharmacists are tireless responders on the front lines of health care as our nation faces the COVID-19 pandemic.
APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.